Please assess the completion status of the following clinical trial:

Trial Title: A Randomised Multi-centre Study to Compare the Long-term Performance of the Future Hip to 3 Other Implants in Primary Total Hip Replacement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~i) Administrative - The subject is able to understand the study, is willing to give voluntary, written, informed consent, will co-operate with assessment procedures and is geographically able to comply with the post-operative follow-up regime.~ii) Age - The subject's age is between 18 and 75 years inclusive.~iii) Sex - Male or female subjects may be recruited to the study.~iv) Diagnosis -Subjects must be undergoing primary THR surgery for non-inflammatory degenerative joint disease including osteoarthritis, avascular necrosis, post-traumatic arthritis, fractured neck of femur and non-union of fractured neck of femur, SUFE or Perthes disease.~v) Suitability - Subjects who in the opinion of the Investigator are considered to be suitable for treatment with the devices involved in the study.~Exclusion Criteria:~i) Subjects undergoing revision procedure to the operative hip.~ii) Subjects who have had a previous femoral osteotomy to the operative hip.~iii) Subjects who have a history of active sepsis in the joint.~iv) Subjects who have been diagnosed with primary or secondary carcinomas in the last five years (excluding basal cell carcinoma or cervical carcinoma).~v) Subjects with any condition which may, in the opinion of the Investigator, interfere with the total hip replacement's survival or outcome, e.g. Paget's disease, Charcot's disease.~vi) Subjects with psycho-social disorders which, in the opinion of the Investigator would limit rehabilitation.~vii) Subject's whose weight is \> 100kg.~viii) Subjects with femoral head necrosis on the non-operated side (RSA and DEXA subjects only).~ix) Subjects who have a fracture of the femur \> 6 months old (RSA and DEXA subjects only).~x) Subjects diagnosed as having ankylosing spondylitis (RSA and DEXA subjects only)~xi) Subjects with a known history of poor compliance to medical treatment.

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- European Hip (Type: OTHER): A cementless femoral component for use in total hip replacement
- Zweymüller (Type: ACTIVE_COMPARATOR): A cementless femoral component for use in total hip replacement
- CLS Spotorno (Type: ACTIVE_COMPARATOR): A cementless femoral component for use in total hip replacement

Based on this trial design, predict the completion outcome and termination type (if applicable).